Comparing magnesium and melatonin for treating insomnia in young adults
Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia
This study is testing whether magnesium or melatonin works better to help young adults aged 18 to 40 who have trouble sleeping.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 40 Years |
| Sex | All |
| Sponsor | CMH Kharian Medical College Government |
| Locations | 1 site (Kharan, Punjab Province) |
| Trial ID | NCT06996171 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of magnesium glycinate and melatonin congeners in treating primary insomnia among young adults aged 18 to 40. It focuses on individuals who experience difficulty falling asleep, staying asleep, or achieving restorative sleep, despite having the opportunity to sleep. By targeting a younger demographic, the study aims to provide age-specific insights into insomnia treatment, which has often been overlooked in previous research that primarily focused on older adults or those with additional health issues.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy young adults aged 18-40 who have been diagnosed with primary insomnia.
Not a fit: Patients with insomnia caused by known underlying conditions or those with psychiatric illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could offer a new, effective treatment option for young adults suffering from primary insomnia.
How similar studies have performed: While many studies have examined magnesium and melatonin separately, this comparative approach in a younger population is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-40 years * Gender: Male and Females (Non-pregnant \& Non lactating) * Diagnosed cases of primary insomnia according to following criteria: * Difficulty falling asleep, staying asleep or nonrestorative sleep * This difficulty is present despite adequate opportunity \& circumstance to sleep * This impairment in sleep is associated with daytime impairment or distress * This sleep difficulty occurs at least 3 times per week and has been a problem for at least 1 month Exclusion Criteria: * Insomnia due to a known underlying cause * Any psychiatric illness * Active use of sedative hypnotics
Where this trial is running
Kharan, Punjab Province
- CMH Kharian Medical College — Kharan, Punjab Province, Pakistan (Recruiting)
Study contacts
- Study coordinator: Mushayada Irshad, MBBS, MPhil Pharmacology
- Email: mishy2360@gmail.com
- Phone: +923237088421
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.